Skip to content

Enhancing effect of supplement on resting energy metabolism after single oral intake. -A randomized, double blind, placebo controlled, cross-over study-

Enhancing effect of supplement on resting energy metabolism after single oral intake. -A randomized, double blind, placebo controlled, cross-over study- - Enhancing effect of supplement on resting energy metabolism after single oral intake.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035586
Enrollment
20
Registered
2019-02-01
Start date
2019-04-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult males

Interventions

Sponsors

FANCL Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1)Japanese males 20 to 64 years of age. 2)Body mass index >=18.5 kg/m2 and <25 kg/m2. 3)Subjects who have not performed regular exercise at least once a week with in the past year. 4)Subjects who are taking three meals a day (breakfast, lunch, dinner) on a daily basis. 5)Subjects who can life restrictions from two days before for date of admission to human calorie meter to the end of the examination. 6)Subjects who received a sufficient explanation about the purpose and content of this study and have a consent ability and volunteered to participate in the understanding and can agree to this study participation in writing.

Exclusion criteria

Exclusion criteria: 1)Subjects who are undergoing medication suffer from some sort of disease. 2)Subjects who being irregular daily life such as shift worker or midnight work. 3)Subjects who have allergy to the test food or the provided meals and have potentially cause severe allergies to other foods and medicine. 4)Subjects who are likely to develop allergic rhinitis including pollinosis of moderate or higher symptoms during the study period. 5)Subjects who are plans to use medicines, quasi-drugs, food with health claims (food for specified health use), health foods and dietary supplements during the study period. 6)Subjects who have serious medical history or current medical history for liver, kidney, pancreas, heart, lung, circulatory organ, digestive organ, blood, metabolism. 7)Subjects whose HbA1c(NGSP) is more than 6.5 % 8)Subjects who have a habit of smoking. 9)Subjects who are ingesting alcohol in excessive (alcohol in terms of 60 g or more per day). 10)Subjects whose blood donation is more than 200 mL in the past one month or more than 400 mL in the past three months. 11)Subjects who have participated in other clinical trial or whose three months have not elapsed after joining other clinical trials or who have plans to participate in other clinical trials after consented to participation in this study. 12)Subjects who is considered to be inappropriate to attend the present study by the investigator.

Design outcomes

Primary

MeasureTime frame
Area under the curve for postprandial resting energy expenditure.

Secondary

MeasureTime frame
Area under the curve for oxygen consumption(VO2), carbon dioxide output(VCO2), fat oxidation(FOX), and carbohydrate oxdation(COX), and VO2, VCO2, EE, FOX, COX, respiratory quotient, heart rate, and LF/HF of before, 20, 60, 120, 180, 240, 300 minutes after breakfast.

Countries

Japan

Contacts

Public ContactMakoto Ichinohe

CPCC Company Limited Planning & Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026